Choate Investment Advisors’s Boston Scientific BSX Stock Holding History

Choate Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$273K	Buy	6,406 +273	+4%	+$14.8K	﹤0.01%	410
2026 Q1	$385K	Sell	6,133 -1,011	-14%	-$80.9K	0.01%	334
2025 Q4	$681K	Buy	7,144 +575	+9%	+$56.4K	0.01%	269
2025 Q3	$641K	Buy	6,569 +2,829	+76%	+$293K	0.01%	258
2025 Q2	$402K	Sell	3,740 -24	-0.6%	-$2.43K	0.01%	295
2025 Q1	$380K	Sell	3,764 -320	-8%	-$32.2K	0.01%	291
2024 Q4	$365K	Buy	4,084 +680	+20%	+$59.9K	0.01%	302
2024 Q3	$285K	Buy	3,404 +162	+5%	+$12.8K	0.01%	323
2024 Q2	$250K	Sell	3,242 -23	-0.7%	-$1.68K	0.01%	331
2024 Q1	$224K	Sell	3,265 -380	-10%	-$24.4K	0.01%	380
2023 Q4	$211K	Sell	3,645 -308	-8%	-$16.4K	0.01%	357
2023 Q3	$209K	Buy	+3,953	New	+$207K	0.01%	343

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Choate Investment Advisors's BSX Position: Q2 2026 in Review

Choate Investment Advisors increased its Boston Scientific (BSX) stake by 4.5% in Q2 2026, buying an estimated $14.8K and bringing the position to 6,406 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #410.

Choate Investment Advisors first reported a position in BSX in Q3 2023 and has held it in 12 quarters since. The position peaked at $681K in Q4 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Choate Investment Advisors held 6,406 shares of Boston Scientific worth $273K as of Q2 2026.
Choate Investment Advisors bought 273 Boston Scientific shares in Q2 2026, an estimated $14.8K.
Boston Scientific made up ﹤0.01% of Choate Investment Advisors's portfolio in Q2 2026, its #410 holding.
Choate Investment Advisors first reported a position in Boston Scientific in Q3 2023 and has held it in 12 quarters since.
Choate Investment Advisors's Boston Scientific position peaked at $681K in Q4 2025.
1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Choate Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.